• 4271 Citations
  • 36 h-Index
1992 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1992 2020

Filter
Review article
2020

Risk of tuberculosis with anti-tumor necrosis factor-alpha therapy in patients with psoriasis and psoriatic arthritis in Indian population

Raychaudhuri, S., Sarkar, S., Panda, S., Kim, B., Raychaudhuri, S. & Ghosh, A., Jan 1 2020, In : Indian Journal of Dermatology, Venereology and Leprology. 86, 1, p. 1-7 7 p.

Research output: Contribution to journalReview article

Open Access
Psoriatic Arthritis
Latent Tuberculosis
Psoriasis
Tuberculosis
Tumor Necrosis Factor-alpha
2019

Is it possible to discontinue tumor necrosis factor antagonists after psoriasis remission?

Kim, B., Maverakis, E. & Raychaudhuri, S. P., Jan 1 2019, In : Annals of Dermatology. 31, 5, p. 495-501 7 p.

Research output: Contribution to journalReview article

Psoriasis
Tumor Necrosis Factor-alpha
Costs and Cost Analysis
Biological Products
Disease Progression
2017
27 Citations (Scopus)

Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies

Raychaudhuri, S. P., Wilken, R., Sukhov, A. C., Raychaudhuri, S. K. & Maverakis, E. M., Jan 1 2017, In : Journal of Autoimmunity. 76, p. 21-37 17 p.

Research output: Contribution to journalReview article

Psoriatic Arthritis
Early Diagnosis
Therapeutics
Psoriasis
LY2439821
12 Citations (Scopus)

Mechanistic rationales for targeting interleukin-17A in spondyloarthritis

Raychaudhuri, S. P. & Raychaudhuri, S. K., Mar 8 2017, In : Arthritis Research and Therapy. 19, 1, 51.

Research output: Contribution to journalReview article

Interleukin-17
Psoriatic Arthritis
Ankylosing Spondylitis
Autoimmune Diseases
Sacroiliac Joint